Leerink Partnrs Predicts Lower Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Research analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for DENTSPLY SIRONA in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst M. Cherny now expects that the medical instruments supplier will post earnings per share of $0.32 for the quarter, down from their previous estimate of $0.40. Leerink Partnrs has a "Hold" rating on the stock. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q2 2025 earnings at $0.47 EPS, Q3 2025 earnings at $0.51 EPS, FY2025 earnings at $1.84 EPS, FY2026 earnings at $2.02 EPS, FY2027 earnings at $2.35 EPS and FY2028 earnings at $2.69 EPS.

Several other research firms have also commented on XRAY. Evercore ISI reiterated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Morgan Stanley cut their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research report on Tuesday, December 17th. Finally, Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $23.58.

DENTSPLY SIRONA Trading Up 0.4 %

Shares of DENTSPLY SIRONA stock traded up $0.06 during mid-day trading on Monday, hitting $16.21. 864,745 shares of the stock were exchanged, compared to its average volume of 2,563,701. The company has a 50-day simple moving average of $18.65 and a 200 day simple moving average of $21.28. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $3.22 billion, a price-to-earnings ratio of -7.82, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a twelve month low of $15.47 and a twelve month high of $34.28.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be given a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 3.95%. DENTSPLY SIRONA's payout ratio is currently -14.07%.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.52% of the company's stock.

Institutional Trading of DENTSPLY SIRONA

Hedge funds have recently bought and sold shares of the company. Pacer Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after acquiring an additional 4,473,972 shares during the last quarter. Nuance Investments LLC increased its position in shares of DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after purchasing an additional 2,708,097 shares in the last quarter. Norges Bank acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $45,730,000. AQR Capital Management LLC increased its holdings in shares of DENTSPLY SIRONA by 245.1% during the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock worth $54,389,000 after buying an additional 2,054,767 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after acquiring an additional 1,975,404 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.